[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

LT4830B - Tienilazolilalkoksietanaminai, jų gavimas ir jų pritaikymas vaistams - Google Patents

Tienilazolilalkoksietanaminai, jų gavimas ir jų pritaikymas vaistams Download PDF

Info

Publication number
LT4830B
LT4830B LT2000097A LT2000097A LT4830B LT 4830 B LT4830 B LT 4830B LT 2000097 A LT2000097 A LT 2000097A LT 2000097 A LT2000097 A LT 2000097A LT 4830 B LT4830 B LT 4830B
Authority
LT
Lithuania
Prior art keywords
methyl
general formula
pyrazole
thienylmethyl
dimethylamino
Prior art date
Application number
LT2000097A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT2000097A (en
Inventor
Ramon Merce-Vidal
Blas Andaluz-Mataro
Jordi Frigola-Constansa
Original Assignee
Laboratorios Del Dr. Esteve,S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr. Esteve,S.A. filed Critical Laboratorios Del Dr. Esteve,S.A.
Publication of LT2000097A publication Critical patent/LT2000097A/xx
Publication of LT4830B publication Critical patent/LT4830B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LT2000097A 1998-04-15 2000-10-12 Tienilazolilalkoksietanaminai, jų gavimas ir jų pritaikymas vaistams LT4830B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009800793A ES2150353B1 (es) 1998-04-15 1998-04-15 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.

Publications (2)

Publication Number Publication Date
LT2000097A LT2000097A (en) 2001-03-26
LT4830B true LT4830B (lt) 2001-08-27

Family

ID=8303465

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2000097A LT4830B (lt) 1998-04-15 2000-10-12 Tienilazolilalkoksietanaminai, jų gavimas ir jų pritaikymas vaistams

Country Status (31)

Country Link
US (3) US6410582B1 (ru)
EP (1) EP1072266B8 (ru)
JP (1) JP2002511412A (ru)
KR (1) KR100523366B1 (ru)
CN (1) CN1189170C (ru)
AR (1) AR016210A1 (ru)
AT (1) ATE302604T1 (ru)
AU (1) AU754705B2 (ru)
BG (1) BG64891B1 (ru)
BR (1) BR9910124A (ru)
CA (1) CA2328878A1 (ru)
CO (1) CO5011045A1 (ru)
CU (1) CU22960A3 (ru)
CZ (1) CZ298222B6 (ru)
EE (1) EE04739B1 (ru)
ES (1) ES2150353B1 (ru)
GE (1) GEP20032913B (ru)
HU (1) HUP0102585A3 (ru)
IS (1) IS5662A (ru)
LT (1) LT4830B (ru)
LV (1) LV12624B (ru)
NO (1) NO320313B1 (ru)
NZ (1) NZ507573A (ru)
PL (1) PL343512A1 (ru)
RO (1) RO121690B1 (ru)
RU (1) RU2213743C2 (ru)
SI (1) SI20473A (ru)
SK (1) SK285039B6 (ru)
TW (1) TW528756B (ru)
UA (1) UA58589C2 (ru)
WO (1) WO1999052525A1 (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
US6432954B1 (en) * 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
ES2174756B2 (es) * 2001-04-06 2003-11-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
ES2180449B1 (es) * 2001-07-06 2004-01-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
CL2004001034A1 (es) 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1671968A1 (en) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1828175A2 (en) * 2004-12-17 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
ES2303795B1 (es) * 2004-12-27 2009-06-12 Laboratorios Del Dr. Esteve, S.A. Procedimiento para obtener enantiomeros de tienilazolilalcoxietanaminas.
WO2006069767A1 (en) * 2004-12-27 2006-07-06 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1674465A1 (en) 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US20070149590A1 (en) * 2005-08-05 2007-06-28 Garcia Francisco J L Controlled release dosage form of pirazole compounds
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
CN102432845B (zh) * 2011-08-22 2013-03-13 电子科技大学 聚3,4-双乙基羟基噻吩气敏材料及其制备方法
US10071968B2 (en) 2014-12-15 2018-09-11 Esteve Pharmaceuticals S.A. Methyl-1H-pyrazole alkylamine compounds having multimodal activity against pain

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289380A1 (fr) 1987-04-10 1988-11-02 Laboratorios Del Dr. Esteve, S.A. Dérivés d'aryl-hétéroaryl carbinols avec activité analgésique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289380A1 (fr) 1987-04-10 1988-11-02 Laboratorios Del Dr. Esteve, S.A. Dérivés d'aryl-hétéroaryl carbinols avec activité analgésique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
E. SIEGMUND: "A method for evaluating both non-narcotic and narcotic analgesics", PROC SOC EXP BIOL MED, 1957, pages 729

Also Published As

Publication number Publication date
ES2150353A1 (es) 2000-11-16
KR100523366B1 (ko) 2005-10-20
AU3148399A (en) 1999-11-01
US20020188017A1 (en) 2002-12-12
US7129361B2 (en) 2006-10-31
LV12624A (lv) 2001-03-20
IS5662A (is) 2000-10-13
HUP0102585A3 (en) 2002-04-29
KR20010042739A (ko) 2001-05-25
PL343512A1 (en) 2001-08-27
CZ20003764A3 (en) 2001-05-16
RO121690B1 (ro) 2008-02-28
EP1072266B1 (en) 2005-08-24
NO320313B1 (no) 2005-11-21
WO1999052525A1 (es) 1999-10-21
JP2002511412A (ja) 2002-04-16
SI20473A (sl) 2001-08-31
SK285039B6 (sk) 2006-05-04
BG64891B1 (bg) 2006-08-31
CN1303283A (zh) 2001-07-11
TW528756B (en) 2003-04-21
UA58589C2 (ru) 2003-08-15
NZ507573A (en) 2002-07-26
HUP0102585A2 (hu) 2001-12-28
ES2150353B1 (es) 2001-07-01
CZ298222B6 (cs) 2007-07-25
BR9910124A (pt) 2001-01-09
AU754705B2 (en) 2002-11-21
CU22960A3 (es) 2004-06-21
LV12624B (lv) 2001-09-20
NO20005146L (no) 2000-12-14
NO20005146D0 (no) 2000-10-13
EE200000596A (et) 2002-06-17
BG104853A (en) 2001-04-30
CA2328878A1 (en) 1999-10-21
US6410582B1 (en) 2002-06-25
ATE302604T1 (de) 2005-09-15
CO5011045A1 (es) 2001-02-28
EP1072266B8 (en) 2006-10-18
LT2000097A (en) 2001-03-26
RU2213743C2 (ru) 2003-10-10
EP1072266A1 (en) 2001-01-31
US20040162324A1 (en) 2004-08-19
SK15282000A3 (sk) 2001-12-03
CN1189170C (zh) 2005-02-16
EE04739B1 (et) 2006-12-15
AR016210A1 (es) 2001-06-20
GEP20032913B (en) 2003-03-25

Similar Documents

Publication Publication Date Title
LT4830B (lt) Tienilazolilalkoksietanaminai, jų gavimas ir jų pritaikymas vaistams
TWI720272B (zh) 雜芳基苯氧基苯甲醯胺kappa類鴉片配體
JPH05140103A (ja) 新規なｎ−アルキレンピペリジノ化合物及びそのエナンチオマー；これらを合成する方法及びこれらを含む医薬品組成物
IE84467B1 (en) Therapeutic heterocyclic compounds
ZA200402999B (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same.
FR2882054A1 (fr) Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
SK162795A3 (en) N-substituted azaheterocyclic carboxylic acids and esters thereof, preparation method thereof and pharmaceutical compositions containing them
CH674008A5 (ru)
RU2352563C2 (ru) Атропоизомеры производных 3-замещенного-4-арилхинолин-2-она
US9199989B2 (en) N—(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
US20230174525A1 (en) Polymorphs of a hydrochloride salt of pn6047
KR20090103932A (ko) 카나비노이드-ｃｂ1 길항작용과 세로토닌 재흡수 억제가 조합된 화합물
MXPA00010055A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
KR20100100968A (ko) 신규한 피페리딘-4-카복실산 페닐-알킬-아미드 유도체 및 모노아민 신경전달물질 재흡수 억제제로서의 이의 용도
KR840002242B1 (ko) 신규 이미다졸 화합물의 제조방법
JPH07242667A (ja) １−アミノ−２−イミノ−３−メチル−６−オキソ−１，２，３，６−テトラヒドロ−７ｈ−プリン類